Cargando…
Digital innovations for retinal care in diabetic retinopathy
AIM: The purpose of this review is to examine the applications of novel digital technology domains for the screening and management of patients with diabetic retinopathy (DR). METHODS: A PubMed engine search was performed, using the terms “Telemedicine”, “Digital health”, “Telehealth”, “Telescreenin...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9374293/ https://www.ncbi.nlm.nih.gov/pubmed/35962258 http://dx.doi.org/10.1007/s00592-022-01941-9 |
_version_ | 1784767760571564032 |
---|---|
author | Vujosevic, Stela Limoli, Celeste Luzi, Livio Nucci, Paolo |
author_facet | Vujosevic, Stela Limoli, Celeste Luzi, Livio Nucci, Paolo |
author_sort | Vujosevic, Stela |
collection | PubMed |
description | AIM: The purpose of this review is to examine the applications of novel digital technology domains for the screening and management of patients with diabetic retinopathy (DR). METHODS: A PubMed engine search was performed, using the terms “Telemedicine”, “Digital health”, “Telehealth”, “Telescreening”, “Artificial intelligence”, “Deep learning”, “Smartphone”, “Triage”, “Screening”, “Home-based”, “Monitoring”, “Ophthalmology”, “Diabetes”, “Diabetic Retinopathy”, “Retinal imaging”. Full-text English language studies from January 1, 2010, to February 1, 2022, and reference lists were considered for the conceptual framework of this review. RESULTS: Diabetes mellitus and its eye complications, including DR, are particularly well suited to digital technologies, providing an ideal model for telehealth initiatives and real-world applications. The current development in the adoption of telemedicine, artificial intelligence and remote monitoring as an alternative to or in addition to traditional forms of care will be discussed. CONCLUSIONS: Advances in digital health have created an ecosystem ripe for telemedicine in the field of DR to thrive. Stakeholders and policymakers should adopt a participatory approach to ensure sustained implementation of these technologies after the COVID-19 pandemic. This article belongs to the Topical Collection "Diabetic Eye Disease", managed by Giuseppe Querques. |
format | Online Article Text |
id | pubmed-9374293 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Milan |
record_format | MEDLINE/PubMed |
spelling | pubmed-93742932022-08-12 Digital innovations for retinal care in diabetic retinopathy Vujosevic, Stela Limoli, Celeste Luzi, Livio Nucci, Paolo Acta Diabetol Review Article AIM: The purpose of this review is to examine the applications of novel digital technology domains for the screening and management of patients with diabetic retinopathy (DR). METHODS: A PubMed engine search was performed, using the terms “Telemedicine”, “Digital health”, “Telehealth”, “Telescreening”, “Artificial intelligence”, “Deep learning”, “Smartphone”, “Triage”, “Screening”, “Home-based”, “Monitoring”, “Ophthalmology”, “Diabetes”, “Diabetic Retinopathy”, “Retinal imaging”. Full-text English language studies from January 1, 2010, to February 1, 2022, and reference lists were considered for the conceptual framework of this review. RESULTS: Diabetes mellitus and its eye complications, including DR, are particularly well suited to digital technologies, providing an ideal model for telehealth initiatives and real-world applications. The current development in the adoption of telemedicine, artificial intelligence and remote monitoring as an alternative to or in addition to traditional forms of care will be discussed. CONCLUSIONS: Advances in digital health have created an ecosystem ripe for telemedicine in the field of DR to thrive. Stakeholders and policymakers should adopt a participatory approach to ensure sustained implementation of these technologies after the COVID-19 pandemic. This article belongs to the Topical Collection "Diabetic Eye Disease", managed by Giuseppe Querques. Springer Milan 2022-08-12 2022 /pmc/articles/PMC9374293/ /pubmed/35962258 http://dx.doi.org/10.1007/s00592-022-01941-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Review Article Vujosevic, Stela Limoli, Celeste Luzi, Livio Nucci, Paolo Digital innovations for retinal care in diabetic retinopathy |
title | Digital innovations for retinal care in diabetic retinopathy |
title_full | Digital innovations for retinal care in diabetic retinopathy |
title_fullStr | Digital innovations for retinal care in diabetic retinopathy |
title_full_unstemmed | Digital innovations for retinal care in diabetic retinopathy |
title_short | Digital innovations for retinal care in diabetic retinopathy |
title_sort | digital innovations for retinal care in diabetic retinopathy |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9374293/ https://www.ncbi.nlm.nih.gov/pubmed/35962258 http://dx.doi.org/10.1007/s00592-022-01941-9 |
work_keys_str_mv | AT vujosevicstela digitalinnovationsforretinalcareindiabeticretinopathy AT limoliceleste digitalinnovationsforretinalcareindiabeticretinopathy AT luzilivio digitalinnovationsforretinalcareindiabeticretinopathy AT nuccipaolo digitalinnovationsforretinalcareindiabeticretinopathy |